Abstract
IN a highly interesting session delivered at the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) congress 2023, experts presented and discussed a range of exciting new technologies. Specifically, embolic protection devices, a clot aspiration pump, and a device that scores calcified aortic valves were presented, along with an intelligent conversational transcatheter aortic valve implantation (TAVI) agent. Chaim Lotan, Chief Innovation Officer, Hadassah Medical Centre, Israel, chaired the session, encouraging thought provoking discussion surrounding the application of these technologies within the field of interventional cardiology.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
